IP Verse

Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression

Patent No. EP3031920 (titled "Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression") was filed by Ionis Pharmaceuticals on Jul 19, 2011. The application was issued on Aug 21, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANMay 19, 2020TEUTEN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3031920

IONIS PHARMACEUTICALS
Application Number
EP16153949A
Filing Date
Jul 19, 2011
Status
Revoked
Feb 19, 2021
Publication Date
Aug 21, 2019
External Links
Slate, Register , Google Patents